WORK Medical Technology Group LTD
WOKNasdaq
$1.99
↓ -3.9%Jul 17 close · end-of-day
Price
1Y↓ -100.0%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$57.7M
Enterprise Value
$60.0M
P/E
—
P/S
5.9
P/B
3.1
EV/EBITDA
—
PEG
—
FCF Yield
8.5%
Dividend Yield
—
Revenue (TTM)
$9.8M
Net Income (TTM)
-$1.1M
Free Cash Flow (TTM)
$4.9M
Gross Margin
23.8%
Operating Margin
—
Net Margin
-10.9%
ROE
-5.9%
ROIC
—
Debt / Equity
0.3
Net Cash
-$2.3M
Return 1Y
-100.0%
Company profile
We are a holding company incorporated in the Cayman Islands. As a holding company with no material operations of our own, we conduct all of our operations through our operating entities established in the PRC, primarily Work Hangzhou, our wholly owned subsidiary, and its subsidiaries (collectively referred to herein as the “PRC subsidiaries”). Our principal executive offices are located at Floor 23, No. 2 Tonghuinan Road, Hangzhou, Zhejiang Province, the PRC. Our registered office in the Cayman Islands is at the offices of Tricor Services (Cayman Islands) Limited, Second Floor, Century Yard, Cricket Square, P.O. Box 902, Grand Cayman, KY1-1103, Cayman Islands. Our agent for service of process in the United States is Cogency Global Inc., located at 122 East 42nd Street, 18th Floor, New York.
- CEO
- Shuang Wu
- Sector
- Manufacturing
- Industry
- Medical Equipment
Earnings
No reported earnings periods on file.
Financial statements
| Line item | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Revenue | $19.7M | $13.6M | $11.5M | $9.8M |
| Gross profit | $4.4M | $4.1M | $2.9M | $2.3M |
| Operating income | — | — | — | — |
| Net income | $865,210.00 | $112,030.00 | -$3.5M | -$1.1M |
| Diluted EPS | $0.07 | $0.01 | -$0.27 | -$0.04 |
| Operating cash flow | -$2.3M | $2.2M | -$2.2M | $6.2M |
| Free cash flow | -$4.3M | $1.8M | -$11.5M | $4.9M |
| Gross margin | 22.4% | 30.5% | 24.9% | 23.8% |
| Operating margin | — | — | — | — |
| Net margin | 4.4% | 0.8% | -30.4% | -10.9% |
No quarterly data.
Company news
Jun 16, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
No insider transactions in the last 12 months.
No insider transactions on file.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.